MGC Pharmaceuticals Limited
MGCLF · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$20,824 | -$20,347 | -$15,870 | -$18,763 |
| Dep. & Amort. | $752 | $405 | $643 | $481 |
| Deferred Tax | -$2,091 | $507 | -$6,444 | -$1,290 |
| Stock-Based Comp. | $2,657 | $644 | $1,648 | $855 |
| Change in WC | $2,070 | $1,961 | -$3,510 | $527 |
| Other Non-Cash | $5,451 | $4,672 | $11,544 | $8,233 |
| Operating Cash Flow | -$11,985 | -$12,158 | -$11,990 | -$9,957 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$190 | -$2,693 | -$3,327 | -$962 |
| Net Acquisitions | $0 | $151 | -$373 | -$8 |
| Inv. Purchases | $0 | -$156 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $303 | $0 |
| Other Inv. Act. | $796 | $1,586 | $1,904 | -$8 |
| Investing Cash Flow | $606 | -$1,111 | -$1,494 | -$970 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2,769 | $9,939 | $11,557 | $10,646 |
| Stock Repurch. | -$318 | -$764 | -$1,203 | -$788 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,732 | $9,738 | $17,051 | $10,462 |
| Financing Cash Flow | $9,732 | $9,738 | $17,051 | $10,462 |
| Forex Effect | -$9 | -$15 | -$8 | -$16 |
| Net Chg. in Cash | -$1,647 | -$3,547 | $3,560 | -$481 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,886 | $5,433 | $1,873 | $2,354 |
| End Cash | $240 | $1,886 | $5,433 | $1,873 |
| Free Cash Flow | -$12,175 | -$14,851 | -$15,317 | -$10,919 |